Pure high-grade papillary urothelial bladder cancer: a luminal-like subgroup with potential for targeted therapy.

Tician SchnitzlerNadina Ortiz-BrüchleUrsula SchneiderIsabella LurjeKarolina GuricovaAlexander BuchnerGerald Bastian SchulzAxel HeidenreichNadine Therese GaisaRuth KnüchelStefan Garczyk

Published in: Cellular oncology (Dordrecht) (2020)

Our data should help guiding the selection of targeted therapies for investigation in future clinical trials and, additionally, may provide a basis for prospective mechanistic studies of pTa HG pathogenesis.

Keyphrases

high grade
clinical trial
low grade
phase iii
electronic health record
current status
case control
big data
fluorescent probe
phase ii
human health
clear cell
open label
living cells
risk assessment
study protocol
double blind
single molecule